Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer
Abstract Gene expression signatures have been used to predict the outcome of chemotherapy for breast cancer. The nucleosome footprint of cell-free DNA (cfDNA) carries gene expression information of the original tissues and thus may be used to predict the response to chemotherapy. Here we carried out...
Guardado en:
Autores principales: | Xu Yang, Geng-Xi Cai, Bo-Wei Han, Zhi-Wei Guo, Ying-Song Wu, Xiaoming Lyu, Li-Min Huang, Yuan-Bin Zhang, Xin Li, Guo-Lin Ye, Xue-Xi Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b031bb6976c4e6e965caea8634927ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasma-Derived Extracellular Vesicles Circular RNAs Serve as Biomarkers for Breast Cancer Diagnosis
por: Li Lin, et al.
Publicado: (2021) -
Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis
por: Xi Zhang, et al.
Publicado: (2021) -
SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer
por: Weipeng Zhao, et al.
Publicado: (2021) -
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021) -
Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Ben‐Yuan Jiang, et al.
Publicado: (2021)